• Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

  • Feb 6 2024
  • Length: 12 mins
  • Podcast

Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

Listen for free

View show details

  • Summary

  • Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents.

    Related Content:

    • Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
    Show More Show Less
Show More Show Less

What listeners say about Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.